NPI: 1811956279 · MONTEREY PARK, CA 91754 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,257 | $1.83M |
| 2019 | 11,129 | $614K |
| 2020 | 12,993 | $916K |
| 2021 | 14,415 | $780K |
| 2022 | 12,638 | $582K |
| 2023 | 16,355 | $985K |
| 2024 | 14,971 | $661K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 52,721 | 4,937 | $6.01M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,100 | 1,707 | $208K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,002 | 1,258 | $68K |
| A4657 | Syringe, with or without needle, each | 6,586 | 1,869 | $31K |
| J1756 | Injection, iron sucrose, 1 mg | 6,004 | 1,961 | $29K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 41 | 28 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,173 | 688 | $4K |
| 83970 | 1,074 | 989 | $3K | |
| 82728 | 870 | 796 | $2K | |
| 83550 | 695 | 626 | $1K | |
| 83540 | 881 | 802 | $829.14 | |
| 90662 | 84 | 79 | $685.70 | |
| 90674 | 98 | 91 | $605.67 | |
| 85041 | 879 | 818 | $311.18 | |
| 85048 | 875 | 812 | $253.21 | |
| G0008 | Administration of influenza virus vaccine | 131 | 123 | $155.38 |
| 0250 | 3,432 | 257 | $87.66 | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 86 | 70 | $15.40 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 12 | 12 | $0.00 |
| 85045 | 14 | 13 | $0.00 |